Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan; College of Medicine, National Taiwan University, Taipei, Taiwan.
Department of Dermatology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
J Formos Med Assoc. 2024 Dec;123(12):1228-1238. doi: 10.1016/j.jfma.2023.12.012. Epub 2023 Dec 30.
Hidradenitis suppurativa (HS) is a chronic inflammatory follicular disease characterized by painful, recurrent, inflamed lesions most commonly occurring in the axillary, inguinal, and anogenital regions. HS can inflict immense physical and psychological impact on patients who suffer from this distressing disease. Management of HS generally requires combining various medical and procedural treatment modalities; however, the disease is often recalcitrant to conventional treatments. In light of recent evidence supporting the effectiveness of biologic agents in the treatment of HS, the Taiwanese Dermatological Association established an expert panel of nine dermatologists to develop consensus statements aimed to provide up-to-date evidence-based guidance in optimizing HS patient management in Taiwan. The recommendations described in the statements were summarized in a management algorithm in terms of general care, topical treatment, systemic treatment, and procedural treatment.
化脓性汗腺炎（HS）是一种慢性炎症性毛囊疾病，其特征是疼痛、反复发作、炎症性病变，最常见于腋窝、腹股沟和会阴部。HS 会给患有这种痛苦疾病的患者带来巨大的身心影响。HS 的治疗通常需要结合各种医学和程序治疗方法；然而，这种疾病通常对传统治疗方法有抗药性。鉴于最近有证据支持生物制剂在 HS 治疗中的有效性，台湾皮肤科协会成立了一个由九位皮肤科医生组成的专家小组，制定了共识声明，旨在为台湾的 HS 患者管理提供最新的基于证据的指导。声明中描述的建议以管理算法的形式总结，包括一般护理、局部治疗、系统治疗和程序治疗。
